Horizon Kinetics Asset Management LLC Galectin Therapeutics Inc Transaction History
Horizon Kinetics Asset Management LLC
- $6.03 Billion
- Q3 2024
A detailed history of Horizon Kinetics Asset Management LLC transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Horizon Kinetics Asset Management LLC holds 51,484 shares of GALT stock, worth $63,840. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,484
Previous 53,742
4.2%
Holding current value
$63,840
Previous $121,000
16.53%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding GALT
# of Institutions
93Shares Held
9.69MCall Options Held
1.16MPut Options Held
1.98M-
Vanguard Group Inc Valley Forge, PA2.13MShares$2.65 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$1.94 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.18MShares$1.47 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA863KShares$1.07 Million0.0% of portfolio
-
Commonwealth Equity Services, LLC483KShares$599,2470.0% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $73.7M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...